1. Executive Summary (Confidence: High)

Senbiosys, a spin-off from the EPFL (École Polytechnique Fédérale de Lausanne), has established itself as a pioneer in miniaturized optoelectronics. Its flagship product, the Velia Ring (formerly Iris), is a breakthrough in the wearable longevity market, offering the "world's slimmest" form factor at 5.2mm. The company’s patented 360° Sensor Constellation technology addresses the critical flaw of data gaps caused by ring rotation, ensuring continuous, medical-grade data flow. Having raised CHF 5 million in traditional capital and an additional CHF 1.5 million through highly successful crowdfunding campaigns, Senbiosys is transitioning from a research-focused entity into a major consumer health player.